RNLS

RNLS

Target · Secreted flavoenzyme

RNLS Renalase, FAD dependent amine oxidase

RNLS (renalase, FAD dependent amine oxidase) is a secreted flavoprotein enzyme released by the kidney that circulates in blood and modulates cardiac function and systemic blood pressure. It is also known as C10orf59 and FLJ11218. Browse Assay Genie's current range of RNLS research reagents below, or read on for the biology behind the target.

Secreted enzyme hormoneFAD-dependent oxidoreductaseLowers blood pressure in vivo
342 aa
Protein length
~38 kDa
Molecular weight
10q23.31
Gene locus
EC 1.6.3.5
Enzyme class
Target information

What is RNLS (renalase, FAD dependent amine oxidase)?

RNLS catalyses the oxidation of the less abundant 1,2-dihydro-beta-NAD(P) and 1,6-dihydro-beta-NAD(P) to form beta-NAD(P)(+). It is described as an enzyme hormone: it is secreted by the kidney, circulates in blood and modulates cardiac function and systemic blood pressure. In vivo, renalase lowers blood pressure by decreasing cardiac contractility and heart rate and by preventing a compensatory increase in peripheral vascular tone. This suggests a causal link to increased plasma catecholamine levels and heightened cardiovascular risk. High concentrations of catecholamines activate plasma renalase and promote its secretion and synthesis.

The RNLS gene encodes a protein of the renalase family and belongs to the HGNC gene groups for flavoproteins and oxidoreductases. The protein is secreted and is located in the extracellular region. According to the NCBI Gene summary, it enables NADH binding, epinephrine binding and monoamine oxidase activity, and is involved in the negative regulation of blood pressure and of heart rate.

The gene was previously designated chromosome 10 open reading frame 59 (C10orf59). RNLS is implicated in essential hypertension, hypertension and stroke, and is described as a biomarker of end stage renal disease. Mouse and rat orthologs are both named Rnls, which allows the biology of this renal-cardiovascular enzyme to be studied in common rodent models.

Blood pressure regulation

RNLS lowers blood pressure in vivo and is involved in the negative regulation of blood pressure, making it a focus for hypertension research.

Cardiac function

Renalase decreases cardiac contractility and heart rate, so RNLS is studied in work on cardiac physiology and cardiovascular risk.

Catecholamine signalling

High catecholamine concentrations activate renalase and promote its secretion and synthesis, linking RNLS to catecholamine biology.

Renal disease biomarkers

RNLS is secreted by the kidney and is described as a biomarker of end stage renal disease, with links to stroke and hypertension.

Background

RNLS frequently asked questions

What does RNLS do?

RNLS is a secreted FAD-dependent enzyme that oxidises 1,2-dihydro- and 1,6-dihydro-beta-NAD(P) to beta-NAD(P)(+). Released by the kidney, it circulates in blood and lowers blood pressure in vivo by decreasing cardiac contractility and heart rate and preventing a compensatory rise in peripheral vascular tone.

What other names are used for RNLS?

RNLS is the HGNC symbol for renalase, FAD dependent amine oxidase. Aliases and previous symbols include renalase, FLJ11218 and C10orf59, the last derived from the earlier name chromosome 10 open reading frame 59. UniProt lists the protein simply as Renalase.

Is RNLS conserved in mouse and rat, and is it linked to disease?

Yes, both mouse and rat have an ortholog named Rnls. RNLS is implicated in essential hypertension, hypertension and stroke, and is described as a biomarker of end stage renal disease. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other flavoenzymes, amine oxidases, catecholamine-pathway proteins and cardiovascular and renal markers studied alongside renalase.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q5VYX0; product specifications from Assay Genie datasheets.

RNLS Product listing